Clarity Financial LLC raised its stake in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 4.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,002 shares of the company’s stock after buying an additional 92 shares during the quarter. Clarity Financial LLC’s holdings in Kimberly-Clark were worth $285,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD increased its stake in Kimberly-Clark by 19.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock worth $762,279,000 after purchasing an additional 944,920 shares during the period. Capital World Investors increased its stake in Kimberly-Clark by 17.8% during the first quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock worth $293,559,000 after purchasing an additional 342,790 shares during the period. Dimensional Fund Advisors LP increased its stake in Kimberly-Clark by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock worth $267,383,000 after purchasing an additional 354,501 shares during the period. Marshall Wace LLP increased its stake in Kimberly-Clark by 48.4% during the second quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock worth $213,539,000 after purchasing an additional 503,839 shares during the period. Finally, ProShare Advisors LLC increased its stake in Kimberly-Clark by 9.8% during the first quarter. ProShare Advisors LLC now owns 1,487,835 shares of the company’s stock worth $192,451,000 after purchasing an additional 132,576 shares during the period. Institutional investors and hedge funds own 76.29% of the company’s stock.
Kimberly-Clark Price Performance
Shares of NYSE KMB opened at $133.74 on Tuesday. Kimberly-Clark Co. has a 1-year low of $117.67 and a 1-year high of $149.30. The company has a debt-to-equity ratio of 4.77, a current ratio of 0.83 and a quick ratio of 0.55. The stock has a fifty day moving average price of $141.79 and a 200 day moving average price of $139.25. The company has a market cap of $44.60 billion, a PE ratio of 17.35, a P/E/G ratio of 2.83 and a beta of 0.40.
Analysts Set New Price Targets
A number of analysts have issued reports on the stock. StockNews.com lowered shares of Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 30th. Royal Bank of Canada restated an “outperform” rating and set a $165.00 target price on shares of Kimberly-Clark in a research note on Wednesday, October 23rd. Argus upgraded shares of Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. Deutsche Bank Aktiengesellschaft increased their price objective on Kimberly-Clark from $146.00 to $147.00 and gave the company a “hold” rating in a report on Tuesday, October 8th. Finally, Piper Sandler increased their price objective on Kimberly-Clark from $167.00 to $174.00 and gave the company an “overweight” rating in a report on Thursday, July 11th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $149.93.
View Our Latest Stock Analysis on KMB
Kimberly-Clark Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories
- Five stocks we like better than Kimberly-Clark
- Health Care Stocks Explained: Why You Might Want to Invest
- 2 Stocks Spinning Off Divisions to Boost Shareholder Value
- 5 Top Rated Dividend Stocks to Consider
- Is Eli Lilly a Buy? Analyst Confidence Grows for 2025
- Compound Interest and Why It Matters When Investing
- Why Warren Buffett’s 1999 Market Warning Still Matters Today
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.